Adicon Holdings Limited logo

Adicon Holdings Limited

9860.HK

HKSEHealthcareMedical - Diagnostics & Research

Latest quote

HK$3.76

+HK$0.10 · +2.73%

Aug 24, 11:17 AM HKTData delayed

9860.HK company overview

Historical prices · Market data may be delayed.

Company profile

Company website

Adicon Holdings Limited operates as an investment vehicle, supplying a range of medical testing solutions across the People's Republic of China. Its core business encompasses diagnostic testing for medical applications, analytical services tailored for research and development initiatives, and comprehensive support for both research and clinical trials. Beyond these services, the company actively participates in the exchange of medical testing apparatus and the distribution of various healthcare-related commodities. The firm was established in 2004, with its principal corporate offices located in Hangzhou, China.

Industry
Medical - Diagnostics & Research
Sector
Healthcare
Headquarters
CN
CEO
Legang Wang
Listed since
Jun 30, 2023
Employees
5,071

Market position

Day range

Current HK$3.76

52-week range

Current HK$3.76

Open
HK$3.67
Previous close
HK$3.66
Volume
1.5K
0.01× average
Average volume
157.52K
Average daily volume
Market cap
2.7B HKD
Beta
0.26
Market reference 1
50-day average
HK$3.7239
+0.97% above average
200-day average
HK$4.4395
-15.31% below average

Earnings

Latest EPS result
0.04

EPS: actual versus estimate

Recent quarterly results

ActualEstimate
Estimates unavailable
Quarterly EPS actual values compared with estimates0.190.140.090.04Q3 '23Q3 '24Q3 '25
Q3 2023, reported Aug 23, 2023: actual 0.154, estimate —, surprise —, Comparison unavailable. Q3 2024, reported Aug 30, 2024: actual 0.15, estimate —, surprise —, Comparison unavailable. Q3 2025, reported Aug 22, 2025: actual 0.044, estimate —, surprise —, Comparison unavailable.

Revenue: actual versus estimate

Recent quarterly results

ActualEstimate
Estimates unavailable
Quarterly Revenue actual values compared with estimates1.85B1.67B1.5B1.32BQ3 '23Q3 '24Q3 '25
Q3 2023, reported Aug 23, 2023: actual 1.78B HKD, estimate —, surprise —, Comparison unavailable. Q3 2024, reported Aug 30, 2024: actual 1.57B HKD, estimate —, surprise —, Comparison unavailable. Q3 2025, reported Aug 22, 2025: actual 1.39B HKD, estimate —, surprise —, Comparison unavailable.

9860.HK peers

ETFs holding 9860.HK

Funds reporting this stock among their holdings, ordered by reported position size.

Continue in GoAI

Research 9860.HK

research.disclaimer